This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Irritable Bowel Syndrome
and you are
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

Brain-derived neurotrophic factor (BDNF), originally known to be a member of the nerve growth factor family, has aroused attention as a modulator in visceral hyperalgesia recently. Visceral hypersensitivity is recognized as a clinical hallmark in IBS patients. So in this study, the investigators will focus on the role of BDNF in colonic hyperalgesia in IBS patients.
Tris trial is registered with FDA with number: NCT00925223. The sponsor of the trial is Shandong University and it is looking for 30 volunteers for the current phase.
Official trial title:
Study of Brain-derived Neurotrophic Factor in Visceral Hyperalgesia in IBS Patients